Back to GALE Stock Lookup

Galena Biopharma (GALE) – Press Releases

Oct 14, 2014 07:05 AM Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan
Oct 14, 2014 07:05 AM Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan
Oct 8, 2014 07:05 AM Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination
Oct 8, 2014 07:05 AM Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination
Sep 25, 2014 04:15 PM Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update
Sep 25, 2014 04:15 PM Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update
Sep 9, 2014 07:05 AM Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial
Sep 9, 2014 07:05 AM Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial
Sep 3, 2014 07:05 AM Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
Sep 3, 2014 07:05 AM Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
Aug 21, 2014 07:05 AM Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
Aug 21, 2014 07:05 AM Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
Aug 11, 2014 04:35 PM Galena Biopharma Reports Second Quarter 2014 Results
Aug 11, 2014 04:35 PM Galena Biopharma Reports Second Quarter 2014 Results
Aug 11, 2014 08:00 AM Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014
Jul 29, 2014 07:05 AM Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014
Jul 29, 2014 07:05 AM Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014
Jul 22, 2014 07:05 AM Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film
Jul 1, 2014 07:05 AM Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S)
Jun 19, 2014 07:05 AM Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference
Jun 17, 2014 07:05 AM Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers
Jun 2, 2014 07:05 AM Galena Biopharma Presents GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting
May 30, 2014 07:05 AM Galena Biopharma to Present at the Jefferies 2014 Global Healthcare Conference
May 21, 2014 07:05 AM Galena Biopharma to Present GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting
Apr 30, 2014 07:05 AM Galena Biopharma to Present at the 39th Annual Deutsche Bank Health Care Conference
Apr 28, 2014 07:05 AM Galena Biopharma Announces Department of Defense Grant for NeuVax(TM) (nelipepimut-S) Clinical Trial
Apr 25, 2014 07:05 AM Galena Biopharma to Report First Quarter 2014 Financial Results on Tuesday, May 6, 2014
Apr 24, 2014 07:05 AM Galena Biopharma Research Pioneer Presented With 2014 Award for Excellence in Technology Transfer
Apr 3, 2014 07:05 AM Galena Biopharma to Present at the 13th Annual Needham Healthcare Conference
Mar 20, 2014 07:05 AM Galena Biopharma Participates in Two Upcoming Conferences
Mar 17, 2014 04:35 PM Galena Biopharma Reports Fourth Quarter and Year End 2013 Results
Mar 10, 2014 09:35 AM Lawsuit on Behalf of Investors in Galena Biopharma Inc (GALE) Announced by Shareholders Foundation
Mar 4, 2014 07:05 AM Galena Biopharma to Present at the 26th Annual ROTH Conference
Mar 3, 2014 07:05 AM Galena Biopharma Launches Galena Patient Services (GPS)
Feb 6, 2014 07:05 AM Galena Biopharma to Present at the 2014 Leerink Global Healthcare Conference
Feb 4, 2014 07:05 AM Galena Biopharma to Present at the 16th Annual BIO CEO & Investor Conference
Jan 17, 2014 07:05 AM Galena Biopharma to Present at the Noble Financial Capital Markets "X" Tenth Annual Equity Conference
Jan 14, 2014 07:05 AM Galena Biopharma and Dr. Reddy's Announce Strategic Partnership for NeuVax(TM) in India
Jan 13, 2014 07:05 AM Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Jan 7, 2014 07:05 AM Galena Biopharma Enrolls First Patient in GALE-301 (Folate Binding Protein (FBP)) Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer

Back to GALE Stock Lookup